---
title: "Determinants of Access to Autism Diagnostic Services: Systematic Review and Meta-analysis"
id: "medrxiv-22-determinants-of-access-to-autism-spectrum-disorder-diagnostic-services-a"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-22-determinants-of-access-to-autism-spectrum-disorder-diagnostic-services-a"
content_type: "clinical_feed_article"
specialty: "Pediatrics"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.26.26361221v1?rss=1"
published_at: "2026-08-27T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Determinants of Access to Autism Diagnostic Services: Systematic Review and Meta-analysis
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-22-determinants-of-access-to-autism-spectrum-disorder-diagnostic-services-a
- **Specialty:** [Pediatrics](https://medichelpline.com/clinical-feed/pediatrics.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.26.26361221v1?rss=1)
- **Published At:** 2026-08-27T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This systematic review and meta-analysis synthesized evidence on factors affecting access to **autism spectrum disorder (ASD)** diagnostic services across the pathway from recognition and referral to diagnostic completion and timely diagnosis. - The authors searched multiple databases and grey literature for studies published from January 2004 to December 2024 and screened 4,362 records after de-duplication; 22 unique studies met inclusion criteria. - Nine studies provided 23 quantitative effect estimates used in meta-analysis; the rest contributed to a narrative synthesis. Study quality was assessed using the Mixed Methods Appraisal Tool (MMAT). - The pooled overall diagnostic access outcome from the random-effects meta-analysis was 74.1% (95% CI 65.8–81.1%), with high heterogeneity (I2 = 88.4%) and a wide 95% prediction interval (32.8–94.4%). Bayesian analysis produced a concordant pooled estimate (73.3%, 95% CrI 65.3–80.2%). - Outcome domains varied: **diagnostic pathways** showed the highest pooled success (89.3%), **timely diagnosis** 76.3%, and **diagnostic completion** the lowest at 67.1%. - Determinant domains examined included socioeconomic/family/perceptual factors, child developmental/neurobehavioral factors, intervention/care-navigation factors, and provider/clinical recognition factors, with pooled frequentist estimates of 74.2%, 79.5%, 68.0%, and 63.6% respectively. - Meta-regression found determinant category and effect measure explained between-study variation; age group and geographic region did not. Family/socioeconomic and child developmental factors had significantly larger effect sizes. - Sensitivity analyses (e.g., excluding two influential outliers) produced a pooled outcome of 77.1% (95% CI 71.6–81.9%), indicating robustness. Some small-study effects were suggested; trim-and-fill adjusted pooled estimate was 68.4% but had wide CI. - The review highlights substantial context dependence of diagnostic access, the importance of **family/socioeconomic circumstances** and child developmental features, and the need for interventions across the diagnostic pathway and more longitudinal and implementation research, particularly in low- and middle-income countries. - The preprint reports no competing interests; all data produced are contained in the manuscript. The report has not been peer reviewed and should not alone guide clinical practice.
## Clinical Analysis & Structured Key Points
Determinants of Access to Autism Spectrum Disorder Diagnostic Services: A Systematic Review and Meta-analysis of Factors Associated with Diagnostic Completion, Diagnostic Pathways, and Timely Diagnosis | medRxiv Skip to main content Determinants of Access to Autism Spectrum Disorder Diagnostic Services: A Systematic Review and Meta-analysis of Factors Associated with Diagnostic Completion, Diagnostic Pathways, and Timely Diagnosis View ORCID Profile JOHN KYALO MUTHUKA , Lispah W. Nyambura , Chrisphine K Onyango , View ORCID Profile Kelly Oluoch , View ORCID Profile Mary Kioko , Jancita Maluki , View ORCID Profile Japheth M Nzioki , Sara Kim doi: https://doi.org/10.64898/2026.08.26.26361221 JOHN KYALO MUTHUKA 1 KENYA MEDICAL TRAINING COLLEGE; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for JOHN KYALO MUTHUKA For correspondence: johnmuthuka{at}gmail.com Lispah W. Nyambura 2 4Anderson Centre for autism, Staatsburg, NY.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Chrisphine K Onyango 3 Anderson Center for Autism, New York, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kelly Oluoch 4 Kenya Medical Training College; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Kelly Oluoch Mary Kioko 4 Kenya Medical Training College; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Mary Kioko Jancita Maluki 4 Kenya Medical Training College; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Japheth M Nzioki 5 School of Nursing, Andrews University, Berrien Springs, Michigan, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Japheth M Nzioki Sara Kim 5 School of Nursing, Andrews University, Berrien Springs, Michigan, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Data/Code Preview PDF Abstract Background: Autism spectrum disorder (ASD) is a lifelong neurodevelopmental condition for which timely diagnosis is critical to early intervention, family support, and equitable access to care. However, substantial disparities in access to ASD diagnostic services persist across socioeconomic, geographic, clinical, and health-system contexts. This systematic review and meta-analysis synthesized evidence on determinants of access across the ASD diagnostic pathway, from recognition and referral to diagnostic completion and timely diagnosis. Methods: We systematically searched MEDLINE/PubMed, Embase, Scopus, Web of Science, Global Health, and grey-literature sources for studies published between January 2004 and December 2024. Eligible studies examined determinants of ASD diagnostic completion, diagnostic pathways, diagnostic timeliness, or barriers and facilitators to diagnostic access. Two reviewers independently extracted data and assessed methodological quality using the Mixed Methods Appraisal Tool (MMAT). Quantitatively comparable estimates were synthesized using random-effects models with restricted maximum likelihood estimation. Heterogeneity was assessed using Cochran's Q, I2, tau2, and 95% prediction intervals. Pre-specified subgroup analyses, meta-regression, sensitivity analyses, funnel-plot assessments, and Bayesian random-effects analyses were undertaken. Results: The search identified 4,899 records; after removal of 537 records without associated data, 4,362 records underwent title/abstract screening. 3,800 records were excluded, 562 reports were sought for retrieval, and 450 full-text reports were assessed after 112 could not be retrieved. Ultimately, 22 unique studies met the inclusion criteria. Nine unique studies contributed 23 quantitative effect estimates, while the remaining studies contributed to the narrative synthesis. The evidence covered socioeconomic, geographic, family, communication, screening, child developmental, provider, and health-system determinants. The overall random-effects meta-analysis yielded a pooled diagnostic access outcome of 74.1% (95% CI 65.8-81.1%), with substantial heterogeneity (Qe=209.95, p<0.001; I2=88.4%, 95% CI 79.1-94.4%; tau2=0.691) and a wide 95% prediction interval of 32.8-94.4%. Bayesian analysis produced a highly concordant pooled estimate of 73.3% (95% CrI 65.3-80.2%), with I2=87.5% and tau=0.833, and satisfactory MCMC convergence (R-hat=1.000). By outcome domain, pooled successful outcomes were highest for diagnostic pathways (89.3%, 95% CI 70.1-96.7%), followed by timely diagnosis (76.3%, 95% CI 62.9-86.0%), and lowest for diagnostic completion (67.1%, 95% CI 61.8-72.0%) (Qm=5.98, p=0.050). Timely diagnosis demonstrated particularly high heterogeneity (I2=91.2%), whereas diagnostic completion showed moderate heterogeneity (I2=40.6%). Across determinant domains, frequentist pooled estimates were 79.5% for child developmental/neurobehavioral factors, 74.2% for family/socioeconomic/perceptual factors, 68.0% for intervention/care-navigation factors, and 63.6% for provider/clinical recognition factors. Bayesian estimates were 76.7% (BF=53.76), 72.9% (BF=226.32), 64.3% (BF=25.60), and 53.7% (BF=0.684), respectively. Meta-regression indicated that determinant category (Qm=13.48, p=0.004) and effect measure (Qm=7.81, p=0.020) significantly explained between-study variation, whereas age group (p=0.203) and geographic region (p=0.453) did not. Family/socioeconomic factors had significantly larger effect sizes (B=2.703, 95% CI 0.661-4.744; p=0.009), as did child developmental/neurobehavioral factors (B=1.516, 95% CI 0.047-2.985; p=0.043). Potential small-study effects were detected by two of three asymmetry tests, although the Rosenthal fail-safe N was 1,723. Trim-and-fill identified seven potentially missing estimates, with an adjusted pooled effect of 68.4% (95% CI 27.7-109.1%). Importantly, exclusion of two influential outlying estimates produced a pooled outcome of 77.1% (95% CI 71.6-81.9%), indicating that the principal finding was robust. Conclusions: Approximately three-quarters of observed ASD diagnostic outcomes represented successful access, but the substantial heterogeneity indicates that diagnostic access is highly context-dependent. Families were more likely to successfully navigate diagnostic pathways than to complete diagnostic assessment, while timely diagnosis showed the greatest variability across settings. Family and socioeconomic circumstances and child developmental characteristics emerged as particularly important determinants, whereas provider-related effects were more heterogeneous and uncertain. Improving equitable ASD diagnosis requires interventions spanning the entire diagnostic pathway, including developmental surveillance, screening, referral coordination, family navigation, provider capacity, specialist availability, and mechanisms to ensure completion of diagnostic assessment. Greater longitudinal and implementation research is particularly needed in low- and middle-income countries, where diagnostic infrastructure and specialist capacity remain limited. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present work are contained in the manuscript Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . Back to top Previous Next Posted August 27, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Determinants of Access to Autism Spectrum Disorder Diagnostic Services: A Systematic Review and Meta-analysis of Factors Associated with Diagnostic Completion, Diagnostic Pathways, and Timely Diagnosis Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Determinants of Access to Autism Spectrum Disorder Diagnostic Services: A Systematic Review and Meta-analysis of Factors Associated with Diagnostic Completion, Diagnostic Pathways, and Timely Diagnosis JOHN KYALO MUTHUKA , Lispah W. Nyambura , Chrisphine K Onyango , Kelly Oluoch , Mary Kioko , Jancita Maluki , Japheth M Nzioki , Sara Kim medRxiv 2026.08.26.26361221; doi: https://doi.org/10.64898/2026.08.26.26361221 Share This Article: Copy Citation Tools Determinants of Access to Autism Spectrum Disorder Diagnostic Services: A Systematic Review and Meta-analysis of Factors Associated with Diagnostic Completion, Diagnostic Pathways, and Timely Diagnosis JOHN KYALO MUTHUKA , Lispah W. Nyambura , Chrisphine K Onyango , Kelly Oluoch , Mary Kioko , Jancita Maluki , Japheth M Nzioki , Sara Kim medRxiv 2026.08.26.26361221; doi: https://doi.org/10.64898/2026.08.26.26361221 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (612) Allergy and Immunology (892) Anesthesia (325) Cardiovascular Medicine (4753) Dentistry and Oral Medicine (473) Dermatology (406) Emergency Medicine (639) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1610) Epidemiology (15797) Forensic Medicine (32) Gastroenterology (1194) Genetic and Genomic Medicine (6965) Geriatric Medicine (726) Health Economics (1050) Health Informatics (4958) Health Policy (1422) Health Systems and Quality Improvement (1731) Hematology (578) HIV/AIDS (1328) Infectious Diseases (except HIV/AIDS) (16227) Intensive Care and Critical Care Medicine (1157) Medical Education (661) Medical Ethics (150) Nephrology (717) Neurology (7159) Nursing (360) Nutrition (1072) Obstetrics and Gynecology (1225) Occupational and Environmental Health (998) Oncology (3563) Ophthalmology (1032) Orthopedics (392) Otolaryngology (445) Pain Medicine (464) Palliative Medicine (139) Pathology (702) Pediatrics (1770) Pharmacology and Therapeutics (730) Primary Care Research (758) Psychiatry and Clinical Psychology (5810) Public and Global Health (9664) Radiology and Imaging (2371) Rehabilitation Medicine and Physical Therapy (1427) Respiratory Medicine (1236) Rheumatology (631) Sexual and Reproductive Health (762) Sports Medicine (572) Surgery (762) Toxicology (106) Transplantation (301) Urology (285)
## Related Clinical Research

- [Adverse neonatal outcomes after operative vaginal delivery in Gondar, Ethiopia: prevalence and ass](https://medichelpline.com/clinical-feed/plos-one-17-adverse-neonatal-outcomes-and-associated-factors-among-births-through-operative.md)
- [Cord blood DNA methylation signature of birthweight persists in high-risk monocorial twin pregnanc](https://medichelpline.com/clinical-feed/medrxiv-19-dna-methylation-signal-of-birthweight-generalizes-to-high-risk-pregnancies-and.md)
- [Robotic walking for children who cannot walk: 12-week RoWaCaWa study on function and activity](https://medichelpline.com/clinical-feed/medrxiv-17-robotic-walking-for-children-who-cannot-walk-rowacawa-impacts-on-physical.md)
- [Expression of Concern over MMAS-8 use in study of medication adherence in older adults with type 2](https://medichelpline.com/clinical-feed/plos-one-12-expression-of-concern-determinants-of-medication-adherence-among-older-adults.md)
- [Pacibekitug, an IL-6 antibody, lowered inflammation in Phase 2 TRANQUILITY — implications for hear](https://medichelpline.com/clinical-feed/stat-news-0-stat-a-novartis-drug-cut-inflammation-can-it-improve-heart-outcomes.md)

## Navigation
- [← Back to Pediatrics Feed](https://medichelpline.com/clinical-feed/pediatrics.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.